Cobalt stimulates HIF-1-dependent but inhibits HIF-2-dependent gene expression in liver cancer cells

Int J Biochem Cell Biol. 2013 Nov;45(11):2359-68. doi: 10.1016/j.biocel.2013.07.025. Epub 2013 Aug 16.

Abstract

Hypoxia-inducible factors (HIFs) are transcriptional regulators that mediate the cellular response to low oxygen. Although HIF-1 is usually considered as the principal mediator of hypoxic adaptation, several tissues and different cell types express both HIF-1 and HIF-2 isoforms under hypoxia or when treated with hypoxia mimetic chemicals such as cobalt. However, the similarities or differences between HIF-1 and HIF-2, in terms of their tissue- and inducer-specific activation and function, are not adequately characterized. To address this issue, we investigated the effects of true hypoxia and hypoxia mimetics on HIF-1 and HIF-2 induction and specific gene transcriptional activity in two hepatic cancer cell lines, Huh7 and HepG2. Both hypoxia and cobalt caused rapid induction of both HIF-1α and HIF-2α proteins. Hypoxia induced erythropoietin (EPO) expression and secretion in a HIF-2-dependent way. Surprisingly, however, EPO expression was not induced when cells were treated with cobalt. In agreement, both HIF-1- and HIF-2-dependent promoters (of PGK and SOD2 genes, respectively) were activated by hypoxia while cobalt only activated the HIF-1-dependent PGK promoter. Unlike cobalt, other hypoxia mimetics such as DFO and DMOG activated both types of promoters. Furthermore, cobalt impaired the hypoxic stimulation of HIF-2, but not HIF-1, activity and cobalt-induced HIF-2α interacted poorly with USF-2, a HIF-2-specific co-activator. These data show that, despite similar induction of HIF-1α and HIF-2α protein expression, HIF-1 and HIF-2 specific gene activating functions respond differently to different stimuli and suggest the operation of oxygen-independent and gene- or tissue-specific regulatory mechanisms involving additional transcription factors or co-activators.

Keywords: Cobalt; EPO; HIF-2α; Hypoxia; SOD2; USF2.

MeSH terms

  • Amino Acids, Dicarboxylic / pharmacology
  • Basic Helix-Loop-Helix Transcription Factors / antagonists & inhibitors
  • Basic Helix-Loop-Helix Transcription Factors / genetics
  • Basic Helix-Loop-Helix Transcription Factors / metabolism*
  • Cell Hypoxia / drug effects
  • Cell Hypoxia / genetics
  • Cell Line, Tumor
  • Cell Nucleus / drug effects
  • Cell Nucleus / metabolism
  • Cobalt / pharmacology*
  • Deferoxamine / pharmacology
  • Erythropoietin / genetics
  • Erythropoietin / metabolism
  • Gene Expression Regulation, Neoplastic / drug effects*
  • Humans
  • Hypoxia-Inducible Factor 1, alpha Subunit / genetics
  • Hypoxia-Inducible Factor 1, alpha Subunit / metabolism*
  • Liver Neoplasms / genetics*
  • Liver Neoplasms / pathology
  • Phosphoglycerate Kinase / genetics
  • Phosphoglycerate Kinase / metabolism
  • Promoter Regions, Genetic / genetics
  • Propanolamines / pharmacology
  • Protein Binding / drug effects
  • Protein Binding / genetics
  • Pyrrolidines / pharmacology
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Superoxide Dismutase / genetics
  • Transcription, Genetic / drug effects
  • Upstream Stimulatory Factors / metabolism

Substances

  • 1-phenyl-2-palmitoylamino-3-pyrrolidino-1-propanol
  • Amino Acids, Dicarboxylic
  • Basic Helix-Loop-Helix Transcription Factors
  • HIF1A protein, human
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Propanolamines
  • Pyrrolidines
  • RNA, Messenger
  • USF2 protein, human
  • Upstream Stimulatory Factors
  • Erythropoietin
  • endothelial PAS domain-containing protein 1
  • Cobalt
  • Superoxide Dismutase
  • superoxide dismutase 2
  • PGK1 protein, human
  • Phosphoglycerate Kinase
  • cobaltous chloride
  • Deferoxamine
  • oxalylglycine